Roger Brent, director of the Molecular Sciences Institute in Berkeley, is a leader in open source biotech: Putting his patents where his principles are, Dr. Brent’s institute has drafted an “Open Source Policy” which commits to “[making] reagents and methods freely available to the research community.” You can see MSI’s open source policy and a… Continue reading Nanotechnology: Lessons from open source biotech
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.